All News

The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are eligible for Hernexeos treatment.

Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges of their myeloma diagnosis.

August is World Cancer Support month, and a time to honor the quiet strength of caregivers and the communities that lift them up.

Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.

Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer, suggesting a possible role for preventative probiotics.

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according to Dr. Jacob Sands.

Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.

Among patients with chronic lymphocytic leukemia, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections.

Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid tumor, and urothelial cancers.

The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.

During World Cancer Support Month, I’m remembering a moment in 2012 a group of teachers — especially Mrs. Reed — lifted me up with unexpected kindness.

The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.

I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.

Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.

I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.

In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.

Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.

In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.

The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.

Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.

During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.

LaShae D. Rolle discusses how maintaining physical activity during active breast cancer treatment may impact a patients mental and emotional well-being.

When my daughter had cancer, my other children carried our family with grace, compassion and strength I didn’t know I’d one day need from them.